JASON TUCKER: Open Payments
NPI 1982165049 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $29 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $88 |
| Lundbeck LLC | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
Products named: ARISTADA, REXULTI, INGREZZA, CAPLYTA, Qelbree, Jornay PM, Xelstrym.
Industry payments across MO — which companies pay providers there.
